To: Joe Hoek who wrote (42405 ) 5/28/1999 12:23:00 PM From: Jenna Read Replies (1) | Respond to of 120523
Not bored here either.. trying to decide which goodies from the Macy's basement clearance sale to keep or to take profits on. The only stock I had to pay 'sticker price' on was MDT, but I was prepared for that gap and its still a good price for this stock MDT upgraded by 3 brokers today Medtronic MDT ABN AMRO Outperform » Buy Medtronic MDT CIBC World Market Hold » Buy Medtronic MDT Prudential Hold » Strong Buy ((((((((((((((((((((((((((((((((((((())))))))))))))))))))))))))))) OCLI... Optical Coating Laboratory reported second quarter revenues of $84 million, up 31% from a year ago. Earnings rose to $0.34 per share versus $0.25, representing a 36% gain and beating the consensus by 3 cents. Last year earnings per share jumped 58%, and over the next five years analysts predict 27.5% annual growth. Of course, there are only three analysts covering OCLI, but with its market capitalization approacing a $1 billion and the series of strong earnings reports, this company will likely garner more attention from Wall Street. By altering the various wavelengths of light, OCLI's products control and enhance light to achieve reflection, refraction, absorption, abrasion resistance, anti-glare and electrical conductivity. OCLI is involved in some pretty exciting growth areas, particularly telecom infrastructure where there is a huge buildout occurring to support exploding demand for data, voice and video communications. OCLI makes bandwidth expanding products for fiber-optic networks, specifically Dense Wavelength Division Multiplexing (DWDM) components. In its display products lineup, OCLI makes anti-glare glass panels for CRT displays, anti-reflective coatings on flat panel displays, and GlareGuard® brand anti-glare, anti-radiaton filters for computer displays. The market for its coating products here should remain strong as PC prices fall but unit shipments continue to grow. Other interesting applications come from OCLI's wholly-owned subsidiary, Flex Products. Flex makes thin-film coatings applied to flexible surface, including solar film for windows and laser absorbing films for printed circuit applications. It also developed the pigment used on US currency for anti-counterfeiting, so when you view a bill at different angles the pigment reflects different colors. The Flex division is expected to be running at full capacity this year, so OCLI is planning a $14 million expansion of production facilities. These light-bending products are fascinating and, more importantly, catering to some fast-growing markets. But with the stock soaring from $15 six months ago to $71.50 currently, the usual "value in small caps" credo no longer applies here. OCLI is trading at 62 times trailing earnings and about 3 times sales. The forward P/E is 46 using FY2000 estimates (OCLI's fiscal year ends in October). For a company expected to grow at less than 30% going forward, this stock is not cheap. [ed. comment: which is why I did not hold through earnings but waited for selling pressure to abate] But some investors prefer to focus on earnings and price momentum, association with hot industries (e.g. fiber-optic communications), and potential catalysts (with only three analysts following it, there is certainly room for new coverage on OCLI). For this camp, Optical Coating Laboratory has some attractive characteristics that can make for a flashy performance. Just don't get "blinded by the light." OCLI recently filed to sell 1.3 million shares in a secondary offering, which would increase the shares outstanding by 11%. Insiders, who currently own 12%, are also selling 250,000 shares as part of the offering.